Cargando…

Regional protein expression in human Alzheimer’s brain correlates with disease severity

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that currently affects 36 million people worldwide with no effective treatment available. Development of AD follows a distinctive pattern in the brain and is poorly modelled in animals. Therefore, it is vital to widen the spatial s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jingshu, Patassini, Stefano, Rustogi, Nitin, Riba-Garcia, Isabel, Hale, Benjamin D., Phillips, Alexander M, Waldvogel, Henry, Haines, Robert, Bradbury, Phil, Stevens, Adam, Faull, Richard L. M., Dowsey, Andrew W., Cooper, Garth J. S., Unwin, Richard D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361956/ https://www.ncbi.nlm.nih.gov/pubmed/30729181 http://dx.doi.org/10.1038/s42003-018-0254-9

Ejemplares similares

Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder
por: Xu, Jingshu, et al.
Publicado: (2016)

Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease
por: Patassini, Stefano, et al.
Publicado: (2019)

Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia
por: Scholefield, Melissa, et al.
Publicado: (2021)

Coenzyme A-Dependent Tricarboxylic Acid Cycle Enzymes Are Decreased in Alzheimer’s Disease Consistent With Cerebral Pantothenate Deficiency
por: Sang, Crystal, et al.
Publicado: (2022)

Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
por: Scholefield, Melissa, et al.
Publicado: (2021)

Plasma metals as potential biomarkers in dementia: a case–control study in patients with sporadic Alzheimer’s disease
por: Xu, Jingshu, et al.
Publicado: (2018)

Vitamin B5 (d-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis
por: Ismail, Nashwah, et al.
Publicado: (2020)

Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson’s Disease Dementia
por: Scholefield, Melissa, et al.
Publicado: (2021)

Extensive multiregional urea elevations in a case-control study of vascular dementia point toward a novel shared mechanism of disease amongst the age-related dementias
por: Philbert, Sasha A., et al.
Publicado: (2023)

Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia
por: Xu, Jingshu, et al.
Publicado: (2016)

Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target
por: Scholefield, Melissa, et al.
Publicado: (2023)

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

Streaming visualisation of quantitative mass spectrometry data based on a novel raw signal decomposition method
por: Zhang, Yan, et al.
Publicado: (2015)

Neuroprotective Effect of Caffeine in Alzheimer’s Disease
por: M Yelanchezian, Y Mukish, et al.
Publicado: (2022)

Quantitative data describing the impact of the flavonol rutin on in-vivo blood-glucose and fluid-intake profiles, and survival of human-amylin transgenic mice
por: Aitken, Jacqueline F., et al.
Publicado: (2016)

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease
por: Kwakowsky, Andrea, et al.
Publicado: (2016)

Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
por: Govindpani, Karan, et al.
Publicado: (2020)

iGluR expression in the hippocampal formation, entorhinal cortex, and superior temporal gyrus in Alzheimer’s disease
por: Yeung, Jason HY, et al.
Publicado: (2022)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

A Multi-Omic Huntington’s Disease Transgenic Sheep-Model Database for Investigating Disease Pathogenesis
por: Mears, Emily R., et al.
Publicado: (2021)

Contrasting Sodium and Potassium Perturbations in the Hippocampus Indicate Potential Na(+)/K(+)-ATPase Dysfunction in Vascular Dementia
por: Philbert, Sasha A., et al.
Publicado: (2022)

Pan-cerebral sodium elevations in vascular dementia: Evidence for disturbed brain-sodium homeostasis
por: Philbert, Sasha A., et al.
Publicado: (2022)

Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
por: Govindpani, Karan, et al.
Publicado: (2017)

Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway
por: Kwakowsky, Andrea, et al.
Publicado: (2018)

Elevated hippocampal copper in cases of type 2 diabetes
por: Philbert, Sasha A., et al.
Publicado: (2022)

The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression
por: Kwakowsky, Andrea, et al.
Publicado: (2020)

Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
por: Govindpani, Karan, et al.
Publicado: (2019)

Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates
por: Schut, Menno H., et al.
Publicado: (2017)

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

Localization of Glycine Receptors in the Human Forebrain, Brainstem, and Cervical Spinal Cord: An Immunohistochemical Review
por: Baer, Kristin, et al.
Publicado: (2009)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Effects of Alterations of Post-Mortem Delay and Other Tissue-Collection Variables on Metabolite Levels in Human and Rat Brain
por: Scholefield, Melissa, et al.
Publicado: (2020)

Mast cell infiltration of the choroid and protease release are early events in age-related macular degeneration associated with genetic risk at both chromosomes 1q32 and 10q26
por: Mcharg, Selina, et al.
Publicado: (2022)

Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation
por: Kassab, Sarah, et al.
Publicado: (2019)

Metabolic disruption identified in the Huntington’s disease transgenic sheep model
por: Handley, Renee. R., et al.
Publicado: (2016)

Development and validation of a methotrexate adherence assay
por: Bluett, James, et al.
Publicado: (2019)

Sex- and age-related changes in GABA signaling components in the human cortex
por: Pandya, Madhavi, et al.
Publicado: (2019)

GABA(A) Receptors Are Well Preserved in the Hippocampus of Aged Mice
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q2t0u8ahuskc1fp35fiek39ja8